Takeda Pharmaceutical Company Limited Increase Decrease Through Other Changes Liabilities Arising From Financing Activities
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease Through Other Changes Liabilities Arising From Financing Activities of JPY 31.02 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities · last filed 2025-06-25
| Period end | Increase Decrease Through Other Changes Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2025-03-31 | 31.02B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 28.97B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 25.63B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 27.07B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 30.28B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 30.56B JPY 20-F · filed 2020-06-24 |
| 2019-03-31 | 9.83B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 2.25B JPY 20-F · filed 2019-06-27 |